OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities
M. Koennecke, Ludger Klimek, Joaquim Mullol, et al.
Allergo Journal International (2018) Vol. 27, Iss. 2, pp. 56-65
Open Access | Times Cited: 69
M. Koennecke, Ludger Klimek, Joaquim Mullol, et al.
Allergo Journal International (2018) Vol. 27, Iss. 2, pp. 56-65
Open Access | Times Cited: 69
Showing 26-50 of 69 citing articles:
Positionspapier: Empfehlungen zur Behandlung der chronischen Rhinosinusitis während der COVID-19-Pandemie im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) – Diese Empfehlungen basieren auf dem EAACI Positionspapier „Treatment of chronic RhinoSinusitis with nasal polyps (CRSwNP) in the COVID-19 pandemics – An EAACI Position Paper”, Allergy, 2020 und wurden auf die …
Ludger Klimek, Sven Becker, Roland Buhl, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 06, pp. 356-364
Open Access | Times Cited: 13
Ludger Klimek, Sven Becker, Roland Buhl, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 06, pp. 356-364
Open Access | Times Cited: 13
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?
Ludger Klimek, Jan Hagemann, Tilman Huppertz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1399-1406
Closed Access | Times Cited: 4
Ludger Klimek, Jan Hagemann, Tilman Huppertz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1399-1406
Closed Access | Times Cited: 4
Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
(2024), pp. 33-48
Open Access | Times Cited: 1
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
(2024), pp. 33-48
Open Access | Times Cited: 1
Cell Adhesion Molecules are Upregulated and May Drive Inflammation in Chronic Rhinosinusitis with Nasal Polyposis
Brennan J Blight, Amarbir S. Gill, Jorgen S. Sumsion, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 585-593
Open Access | Times Cited: 10
Brennan J Blight, Amarbir S. Gill, Jorgen S. Sumsion, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 585-593
Open Access | Times Cited: 10
Empfehlungen zur Überprüfung der Wirksamkeit und Verlaufsdokumentation von Dupilumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2022) Vol. 101, Iss. 11, pp. 855-865
Open Access | Times Cited: 7
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2022) Vol. 101, Iss. 11, pp. 855-865
Open Access | Times Cited: 7
Heterogeneity of NSAID-Exacerbated Respiratory Disease
Marek L. Kowalski
Current Opinion in Pulmonary Medicine (2018) Vol. 25, Iss. 1, pp. 64-70
Closed Access | Times Cited: 10
Marek L. Kowalski
Current Opinion in Pulmonary Medicine (2018) Vol. 25, Iss. 1, pp. 64-70
Closed Access | Times Cited: 10
Positionspapier: Hinweise zur Patienteninformation und -aufklärung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC) – Teil 1: Dupilumab
Ludger Klimek, Achim Beule, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 11, pp. 761-766
Open Access | Times Cited: 9
Ludger Klimek, Achim Beule, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 11, pp. 761-766
Open Access | Times Cited: 9
Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma
Н. В. Бойко, О.Е. Лодочкина, M.M. Kit, et al.
Russian Bulletin of Otorhinolaryngology (2021) Vol. 86, Iss. 2, pp. 43-43
Closed Access | Times Cited: 9
Н. В. Бойко, О.Е. Лодочкина, M.M. Kit, et al.
Russian Bulletin of Otorhinolaryngology (2021) Vol. 86, Iss. 2, pp. 43-43
Closed Access | Times Cited: 9
Dokumentation von Biologika-Therapien bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP): Dupilumab, Omalizumab und Mepolizumab
Ludger Klimek, Ulrike Förster‐Ruhrmann, Achim Beule, et al.
Allergo Journal (2022) Vol. 31, Iss. 6, pp. 24-39
Open Access | Times Cited: 6
Ludger Klimek, Ulrike Förster‐Ruhrmann, Achim Beule, et al.
Allergo Journal (2022) Vol. 31, Iss. 6, pp. 24-39
Open Access | Times Cited: 6
Empfehlungen zur Überprüfung der Wirksamkeit und Verlaufsdokumentation von Mepolizumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 02, pp. 89-99
Closed Access | Times Cited: 3
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 02, pp. 89-99
Closed Access | Times Cited: 3
The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data
Marion San Nicoló, Catalina Högerle, Donata Gellrich, et al.
European Archives of Oto-Rhino-Laryngology (2019) Vol. 277, Iss. 2, pp. 445-452
Closed Access | Times Cited: 8
Marion San Nicoló, Catalina Högerle, Donata Gellrich, et al.
European Archives of Oto-Rhino-Laryngology (2019) Vol. 277, Iss. 2, pp. 445-452
Closed Access | Times Cited: 8
Histopathologic Influences of Tissue Eosinophilia Among Chronic Rhinosinusitis Patients
Ashwin Ganti, Hannah J. Brown, Hannah N. Kuhar, et al.
American Journal of Rhinology and Allergy (2019) Vol. 34, Iss. 3, pp. 331-335
Closed Access | Times Cited: 8
Ashwin Ganti, Hannah J. Brown, Hannah N. Kuhar, et al.
American Journal of Rhinology and Allergy (2019) Vol. 34, Iss. 3, pp. 331-335
Closed Access | Times Cited: 8
Latest advances in chronic rhinosinusitis with nasal polyps endotyping and biomarkers, and their significance for daily practice
Alma Maniu, Maria Perde‐Schrepler, Corina-Bianca Tatomir, et al.
Romanian Journal of Morphology and Embryology (2020) Vol. 61, Iss. 2, pp. 309-320
Open Access | Times Cited: 8
Alma Maniu, Maria Perde‐Schrepler, Corina-Bianca Tatomir, et al.
Romanian Journal of Morphology and Embryology (2020) Vol. 61, Iss. 2, pp. 309-320
Open Access | Times Cited: 8
Immundefekte bei chronischer Rhinosinusitis
Ludger Klimek, Adam Chaker, C. Matthias, et al.
HNO (2019) Vol. 67, Iss. 9, pp. 715-730
Closed Access | Times Cited: 4
Ludger Klimek, Adam Chaker, C. Matthias, et al.
HNO (2019) Vol. 67, Iss. 9, pp. 715-730
Closed Access | Times Cited: 4
Eosinophilie unter Dupilumab bei chronischer Rhinosinusitis mit Polyposis nasi und Asthma bronchiale
Ludger Klimek, M. Spielhaupter, Ali Alali, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 11, pp. 811-812
Closed Access | Times Cited: 4
Ludger Klimek, M. Spielhaupter, Ali Alali, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 11, pp. 811-812
Closed Access | Times Cited: 4
Management of Pediatric Chronic Rhinosinusitis
Jacqueline Alvarado, Pablo Stolovitzky
Current Treatment Options in Allergy (2020) Vol. 7, Iss. 3, pp. 356-369
Closed Access | Times Cited: 4
Jacqueline Alvarado, Pablo Stolovitzky
Current Treatment Options in Allergy (2020) Vol. 7, Iss. 3, pp. 356-369
Closed Access | Times Cited: 4
Hat die ASS-Desaktivierung in Zeiten von Biologika noch einen Stellenwert bei chronischer Rhinosinusitis mit nasaler Polyposis?
Felix Klimek, Ulrike Förster‐Ruhrmann, Jan Hagemann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 484-493
Closed Access
Felix Klimek, Ulrike Förster‐Ruhrmann, Jan Hagemann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 484-493
Closed Access
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significance
Felix Klimek, Christoph Bergmann, Jan Hagemann, et al.
Allergologie select (2024) Vol. 8, Iss. 1, pp. 40-50
Open Access
Felix Klimek, Christoph Bergmann, Jan Hagemann, et al.
Allergologie select (2024) Vol. 8, Iss. 1, pp. 40-50
Open Access
Ergebnisse einer Umfrage zur aktuellen Behandlung der chronischen Rhinosinusitis mit nasalen Polypen
Eric Deuß, Sven Becker, Moritz Meyer, et al.
Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. 09, pp. 646-654
Closed Access
Eric Deuß, Sven Becker, Moritz Meyer, et al.
Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. 09, pp. 646-654
Closed Access
Inflammatory Cytokines in Middle Ear Effusion of Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps With or Without NSAID Intolerance
Anna Suikkila, Annina Lyly, Terhi Savinko, et al.
Otology & Neurotology (2024) Vol. 45, Iss. 7, pp. 765-772
Open Access
Anna Suikkila, Annina Lyly, Terhi Savinko, et al.
Otology & Neurotology (2024) Vol. 45, Iss. 7, pp. 765-772
Open Access
Endotyping of Nasal Polyposis
Ashoke Khanwalkar, Richard J. Harvey
Springer eBooks (2024), pp. 143-164
Closed Access
Ashoke Khanwalkar, Richard J. Harvey
Springer eBooks (2024), pp. 143-164
Closed Access
Role of the TAp63 Isoform in Recurrent Nasal Polyps
Alessandro Terrinoni, Ramona Palombo, Consuelo Pitolli, et al.
Folia Biologica (2019) Vol. 65, Iss. 4, pp. 170-180
Open Access | Times Cited: 3
Alessandro Terrinoni, Ramona Palombo, Consuelo Pitolli, et al.
Folia Biologica (2019) Vol. 65, Iss. 4, pp. 170-180
Open Access | Times Cited: 3
[Immunodeficiency in chronic rhinosinusitis : An important and often underestimated cause].
Ludger Klimek, Adam Chaker, C. Matthias, et al.
(2019) Vol. 67, Iss. 9, pp. 715-730
Closed Access | Times Cited: 3
Ludger Klimek, Adam Chaker, C. Matthias, et al.
(2019) Vol. 67, Iss. 9, pp. 715-730
Closed Access | Times Cited: 3
Positionspapier: ICD-Codierung der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) im ICD-10-GM als Grundlage für eine Therapie mit Biologika
Sven Becker, Martin Laudien, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 05, pp. 349-356
Closed Access | Times Cited: 1
Sven Becker, Martin Laudien, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 05, pp. 349-356
Closed Access | Times Cited: 1
EFFICACY OF RESLIZUMAB IN THE TREATMENT OF ASTHMA AND COMORBID CHRONIC RHINOSINUSITIS WITH POLYPS
Н. В. Бойко, I.V. Stagnieva, О.Е. Лодочкина, et al.
The Bulletin of Contemporary Clinical Medicine (2021) Vol. 14, Iss. 6, pp. 22-27
Open Access | Times Cited: 3
Н. В. Бойко, I.V. Stagnieva, О.Е. Лодочкина, et al.
The Bulletin of Contemporary Clinical Medicine (2021) Vol. 14, Iss. 6, pp. 22-27
Open Access | Times Cited: 3
